Loading…
Imatinib dose reduction after major molecular response in chronic‐phase chronic myeloid leukemia
Li, Zongru, Zhang, Xiaoshuai, Zhao, Yijing, Lu, Linping, Guo, Yong, Gale, Robert Peter, Qin, Yazhen, Jiang, Qian
Published in Cancer (01.01.2025)
Published in Cancer (01.01.2025)
Get full text
Journal Article
Loading…
Optimizing olverembatinib dose in chronic phase chronic myeloid leukemia
Zhang, Xiaoshuai, Yang, Yunfan, Liu, Bingcheng, Du, Xin, Wang, Xiaodong, Zhu, Huanling, Yu, Lu, Li, Zongru, Zhao, Shasha, Yang, Linhua, Ma, Yanping, Meng, Li, Zhang, Yanqing, Li, Guohui, Yang, Lijie, Wang, Baohong, Ran, Xuehong, Huang, Jian, Gao, Na, Wen, Qin, Wen, Yan, Zhao, Yuxia, Zhu, Yu, Han, Yanqiu, Liu, Zhenfang, Weng, Jianyu, Gale, Robert Peter, Zhou, Li, Zhang, Yanli, Jiang, Qian
Published in Haematologica (Roma) (30.04.2025)
Published in Haematologica (Roma) (30.04.2025)
Get full text
Journal Article
Loading…
Loading…
Antibody seroprevalence against SARS-Cov-2 among chronic myeloid leukemia patients
Miranda, Marisol, Bradshaw, Danielle, Farmaha, Jaspreet, Patel, Reeya, Jones, Kimya, Singh, Harmanpreet, Vashisht, Ashutosh, Sahajpal, Nikhil Shri, Kohle, Ravindra, Cortes, Jorge E.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Loading…
Outcomes of veterans diagnosed with chronic myeloid leukemia in the tyrosine kinase inhibitor era
Rosenthal, Matthew Harry, Hung, Stevephen, Yaghi, Omar Shukri, Liu, Shanshan, Gill, Puneet, McKinnell, Zoe, Diao, Guoqing, Jain, Maneesh
Published in Journal of clinical oncology (01.06.2025)
Published in Journal of clinical oncology (01.06.2025)
Get full text
Journal Article
Loading…
MiR-150 Expression in Chronic Myeloid Leukemia: Relation to Imatinib Response
Habib, Eman M, Nosiar, Nahla A, Eid, Manal A, Taha, Atef M, Sherief, Dalia E, Hassan, Asmaa E, Abdel Ghafar, Muhammad T
Published in Laboratory medicine (01.01.2022)
Published in Laboratory medicine (01.01.2022)
Get full text
Journal Article
Loading…
Arterial hypertension assessment in a population with chronic myeloid leukemia
Roa-Chamorro, Ricardo, Jaén-Águila, Fernando, Puerta-Puerta, José Manuel, Torres-Quintero, Lucía, González-Bustos, Pablo, Mediavilla-García, Juan Diego
Published in Scientific reports (19.07.2021)
Published in Scientific reports (19.07.2021)
Get full text
Journal Article
Loading…
Loading…
Loading…
Inflammatory/Immune Adverse Events in Chronic Myeloid Leukemia Patients during Treatment with Bosutinib
Agostani, Elena, Tassistro, Elena, Antolini, Laura, Gambacorti-Passerini, Carlo
Published in Blood (05.11.2024)
Published in Blood (05.11.2024)
Get full text
Journal Article
Loading…
Identification and Targeting of Thomsen–Friedenreich and IL1RAP Antigens on Chronic Myeloid Leukemia Stem Cells Using Bi-Specific Antibodies
Eldesouki, Raghda, Wu, Chengxiang, Saleh, Fayez M, Mohammed, Eman Abdel-Moemen, Younes, Soha, Hassan, Naglaa Elsayed, Brown, Theresa C, Alt, Eckhard U, Robinson, James E, Badr, Fouad Mohamed, Braun, Stephen E
Published in OncoTargets and therapy (01.01.2021)
Published in OncoTargets and therapy (01.01.2021)
Get full text
Journal Article
Loading…
Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors?
Zhang, Xiao-Shuai, Gale, Robert Peter, Huang, Xiao-Jun, Jiang, Qian
Published in Leukemia (01.02.2022)
Published in Leukemia (01.02.2022)
Get full text
Journal Article
Loading…
Bone Marrow CD34+/lin− Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects
Trojani, Alessandra, Pungolino, Ester, Di Camillo, Barbara, Bossi, Luca Emanuele, Palumbo, Cassandra, D’adda, Mariella, Perego, Alessandra, Turrini, Mauro, Elena, Chiara, Borin, Lorenza Maria, Iurlo, Alessandra, Malato, Simona, Spina, Francesco, Latargia, Maria Luisa, Spedini, Pierangelo, Artale, Salvatore, Anghilieri, Michela, Carraro, Maria Cristina, Bucelli, Cristina, Beghini, Alessandro, Cairoli, Roberto
Published in Cancers (18.03.2025)
Published in Cancers (18.03.2025)
Get full text
Journal Article
Loading…
Loading…
Vandetanib drives growth arrest and promotes sensitivity to imatinib in chronic myeloid leukemia by targeting ephrin type‐B receptor 4
Ma, Weina, Zhu, Man, Wang, Bo, Gong, Zhengyan, Du, Xia, Yang, Tianfeng, Shi, Xianpeng, Dai, Bingling, Zhan, Yingzhuan, Zhang, Dongdong, Ji, Yanhong, Wang, Yang, Li, Song, Zhang, Yanmin
Published in Molecular oncology (01.07.2022)
Published in Molecular oncology (01.07.2022)
Get full text
Journal Article
Loading…
Computer-aided design of imatinib derivatives: Overcoming drug-resistance in chronic myeloid leukemia
Gholizadeh, S., Panahi, N., Razzaghi-Asl, N.
Published in Computers in biology and medicine (01.03.2025)
Published in Computers in biology and medicine (01.03.2025)
Get full text
Journal Article
Loading…
Clinicopathologic Correlates and Natural History of Atypical Chronic Myeloid Leukemia
Montalban Bravo, Guillermo, Kanagal-Shamanna, Rashmi, Sasaki, Koji, Masarova, Lucia, Naqvi, Kiran, Jabbour, Elias, DiNardo, Courtney D., Takahashi, Koichi, Konopleva, Marina, Pemmaraju, Naveen, Short, Nicholas J., Issa, Ghayas C., Kadia, Tapan M., Ravandi, Farhad, Daver, Naval, Borthakur, Gautam, Estrov, Zeev E., Khoury, Joseph D., Loghavi, Sanam, Pierce, Sherry A., Bueso-Ramos, Carlos E., Patel, Keyur, Verstovsek, Srdan, Kantarjian, Hagop M., Bose, Prithviraj, Garcia-Manero, Guillermo
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Loading…
Predictive scoring systems for molecular responses in persons with chronic phase chronic myeloid leukemia receiving initial imatinib therapy
Zhang, Xiao-shuai, Gale, Robert Peter, Li, Zi-yu, Zhang, Meng-yu, Huang, Xiao-jun, Jiang, Qian
Published in Leukemia (01.08.2022)
Published in Leukemia (01.08.2022)
Get full text
Journal Article
Loading…
Loading…
Circulating miR-146a expression predicts early treatment response to imatinib in adult chronic myeloid leukemia
Habib, Eman M, Nosiar, Nahla A, Eid, Manal A, Taha, Atef M, Sherief, Dalia E, Hassan, Asmaa E, Abdel Ghafar, Muhammad Tarek
Published in Journal of investigative medicine (01.02.2021)
Published in Journal of investigative medicine (01.02.2021)
Get full text
Journal Article